文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤引流肺静脉中细胞外囊泡长链非编码RNA-p21的表达决定非小细胞肺癌的预后并调节内皮细胞行为。

Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior.

作者信息

Castellano Joan J, Marrades Ramon M, Molins Laureano, Viñolas Nuria, Moises Jorge, Canals Jordi, Han Bing, Li Yan, Martinez Daniel, Monzó Mariano, Navarro Alfons

机构信息

Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain.

Thoracic Oncology Unit, Hospital Clinic, 08036 Barcelona, Spain.

出版信息

Cancers (Basel). 2020 Mar 20;12(3):734. doi: 10.3390/cancers12030734.

DOI:10.3390/cancers12030734
PMID:32244977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140053/
Abstract

Hypoxia-induced upregulation of lincRNA-p21 in tumor tissue was previously shown by our group to be related to poor prognosis in resected non-small cell lung cancer (NSCLC) patients. In the present study, we have evaluated the presence of lincRNA-p21 in extracellular vesicles (EVs) from NSCLC patients and assessed its potential as a prognostic biomarker. High EV lincRNA-p21 levels in blood from the tumor-draining vein were associated with shorter time to relapse and shorter overall survival. Moreover, the multivariate analysis identified high lincRNA-p21 levels as an independent prognostic marker. In addition, lincRNA-p21 was overexpressed in H23 and HCC44 NSCLC cell lines and their derived EVs under hypoxic conditions. Functional assays using human umbilical vein endothelial cells (HUVECs) showed that tumor-derived EVs enriched in lincRNA-p21 affected endothelial cells by promoting tube formation and enhancing tumor cell adhesion to endothelial cells. Additionally, the analysis of selected EV microRNAs related to angiogenesis and metastasis showed that the microRNAs correlated with EV lincRNA-p21 levels in both patients and cell lines. Finally, EV co-culture with HUVEC cells increased the expression of microRNAs and genes related to endothelial cell activation. In conclusion, EV lincRNA-p21 acts as a novel prognosis marker in resected NSCLC patients, promoting angiogenesis and metastasis.

摘要

我们小组之前的研究表明，肿瘤组织中缺氧诱导的lincRNA-p21上调与接受手术切除的非小细胞肺癌（NSCLC）患者的不良预后相关。在本研究中，我们评估了NSCLC患者细胞外囊泡（EVs）中lincRNA-p21的存在情况，并评估了其作为预后生物标志物的潜力。肿瘤引流静脉血中EV lincRNA-p21水平较高与较短的复发时间和较短的总生存期相关。此外，多变量分析确定高lincRNA-p21水平是一个独立的预后标志物。此外，在缺氧条件下，lincRNA-p21在H23和HCC44 NSCLC细胞系及其衍生的EVs中过表达。使用人脐静脉内皮细胞（HUVECs）进行的功能分析表明，富含lincRNA-p21的肿瘤来源EVs通过促进管腔形成和增强肿瘤细胞与内皮细胞的粘附来影响内皮细胞。此外，对与血管生成和转移相关的选定EV微小RNA的分析表明，这些微小RNA在患者和细胞系中均与EV lincRNA-p21水平相关。最后，EV与HUVEC细胞共培养增加了与内皮细胞激活相关的微小RNA和基因的表达。总之，EV lincRNA-p21在接受手术切除的NSCLC患者中作为一种新的预后标志物，促进血管生成和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/d52e4bd3b737/cancers-12-00734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/897dcad7de5e/cancers-12-00734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/5e1545a3f488/cancers-12-00734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/dc46f329a808/cancers-12-00734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/d52e4bd3b737/cancers-12-00734-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/897dcad7de5e/cancers-12-00734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/5e1545a3f488/cancers-12-00734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/dc46f329a808/cancers-12-00734-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de6/7140053/d52e4bd3b737/cancers-12-00734-g004.jpg

相似文献

[1]
Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior.

Cancers (Basel). 2020-3-20

[2]
LincRNA-p21 Impacts Prognosis in Resected Non-Small Cell Lung Cancer Patients through Angiogenesis Regulation.

J Thorac Oncol. 2016-8-2

[3]
LincRNA-p21 Levels Relates to Survival and Post-Operative Radiotherapy Benefit in Rectal Cancer Patients.

Life (Basel). 2020-8-31

[4]
Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer.

J Int Med Res. 2019-1

[5]
LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.

Stem Cell Res Ther. 2018-10-25

[6]
LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.

Clin Exp Med. 2017-2

[7]
Distinct mRNAs in Cancer Extracellular Vesicles Activate Angiogenesis and Alter Transcriptome of Vascular Endothelial Cells.

Cancers (Basel). 2021-4-22

[8]
Smoking Induced Extracellular Vesicles Release and Their Distinct Properties in Non-Small Cell Lung Cancer.

J Cancer. 2019-6-9

[9]
Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery.

Cancers (Basel). 2019-2-21

[10]
Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).

Lung Cancer. 2013-5-10

引用本文的文献

[1]
The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets.

Apoptosis. 2025-6-22

[2]
Exosomes and immune modulation: implications for neuroblastoma immunotherapy.

Front Immunol. 2025-5-27

[3]
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers.

Front Cell Dev Biol. 2025-1-24

[4]
Tumor-associated exosomes in cancer progression and therapeutic targets.

MedComm (2020). 2024-9-7

[5]
Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets.

Noncoding RNA Res. 2024-6-12

[6]
Exosome nanovesicles: biomarkers and new strategies for treatment of human diseases.

MedComm (2020). 2024-7-15

[7]
Endothelial lincRNA-p21 alleviates cerebral ischemia/reperfusion injury by maintaining blood-brain barrier integrity.

J Cereb Blood Flow Metab. 2024-9

[8]
Functional Relevance of Extracellular Vesicle-Derived Long Non-Coding and Circular RNAs in Cancer Angiogenesis.

Noncoding RNA. 2024-2-6

[9]
Emerging role of exosome-derived non-coding RNAs in tumor-associated angiogenesis of tumor microenvironment.

Front Mol Biosci. 2023-8-4

[10]
The therapeutic potential of exosomes in lung cancer.

Cell Oncol (Dordr). 2023-10

本文引用的文献

[1]
Clinical significance of long non-coding RNA HOTTIP in early-stage non-small-cell lung cancer.

BMC Pulm Med. 2019-2-28

[2]
Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery.

Cancers (Basel). 2019-2-21

[3]
Serum lincRNA-p21 expression in primary liver diseases and liver metastatic diseases.

Pathol Res Pract. 2019-4

[4]
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.

J Extracell Vesicles. 2018-11-23

[5]
Long noncoding RNAs as regulators of cancer immunity.

Mol Oncol. 2018-12-13

[6]
LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.

Stem Cell Res Ther. 2018-10-25

[7]
Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.

BMC Genomics. 2018-10-11

[8]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2018-9-12

[9]
miR-330-3p promotes lung cancer cells invasion, migration, and metastasis by directly targeting hSOD2b.

Biotechnol Appl Biochem. 2019-1

[10]
Exosomal lncRNAs as new players in cell-to-cell communication.

Transl Cancer Res. 2018-3

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索